Quitxt Mobile Text Messaging Cessation Research Study - Trial NCT05958667
Access comprehensive clinical trial information for NCT05958667 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Texas Health Science Center at San Antonio and is currently Not yet recruiting. The study focuses on Smoking Cessation. Target enrollment is 1200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The University of Texas Health Science Center at San Antonio
Timeline & Enrollment
N/A
Jan 01, 2024
Aug 01, 2028
Primary Outcome
Smoking cessation
Summary
The health benefits of smoking cessation by age 30 are much greater than cessation later in
 life, including gaining 10 years of life, compared with those who continue to smoke. The goal
 of the proposed study is to evaluate the effectiveness of our bilingual and culturally
 tailored Quitxt mobile cessation intervention. Quitxt provides interactive messages through
 texts or chat with visual and video content employing theory- and evidence-based techniques
 to prompt and sustain cessation. We will recruit 1,200 Latino young adult smokers aged 18-29
 who enroll and agree to make quit attempts, with half randomly assigned (like flipping a
 coin) to receive Quitxt and half to abbreviated text messages with smoking cessation-related
 content and referral to the Texas Department of State Health Services cessation program Yes
 Quit (which has diverse formats, but not explicitly tailored for young Latino adults in South
 Texas). Participants respond to baseline and follow-up assessments at one, three and six
 months after their enrollment, and those who report cessation will be asked to provide saliva
 samples to confirm they quit smoking. Our sample size will be sufficient to detect expected
 higher cessation rates in those who are enrolled in Quitxt than those who are enrolled in
 Texas DSHS Yes Quit. We will publish our results in scientific journals, report them at
 scientific and community meetings, share them on social media, and publicize them widely.
 This study has the potential to advance public health by evaluating the effectiveness of a
 scalable, easily disseminated and adaptable intervention to help young adults, especially
 Latinos, quit smoking and reduce smoking-related cancer and chronic disease morbidity and
 mortality and their associated healthcare costs.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05958667
Non-Device Trial

